" /> Olaparib - CISMeF





Preferred Label : Olaparib;

NCIt related terms : AZD2281; PARP inhibitor AZD2281;

NCIt definition : A small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to and inhibits PARP, inhibiting PARP-mediated repair of single strand DNA breaks; PARP inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of breast, ovarian, and prostate cancers caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. It blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. AZD2281 may cause cancer cells to die. It is a type of targeted therapy agent and a type of poly (ADP-ribose) polymerase inhibitor.;

UNII : WOH1JD9AR8;

InChIKey : FDLYAMZZIXQODN-UHFFFAOYSA-N;

CAS number : 763113-22-0;

Drug name : Lynparza; Olaparix; Olanib;

Molecule name : AZD-2281; KU-0059436; AZD 2281; KU 0059436;

Chemical formula : C24H23FN4O3;

Codes from synonyms : CDR0000657862; CDR0000660871; CDR0000597093; 366;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
02/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.